Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bode

Showing results (321-330 of 756) with videos related to

Pageof 76
Sort By:
Cancer Research|May 17, 2008
The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer developmentDuo Zheng, Ann M Bode, Qing Zhao, et al.
Molecular Carcinogenesis|July 29, 2003
Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cellsAkira Kaji, Yiguo Zhang, Masaaki Nomura, et al.
International Journal of Molecular Medicine|January 24, 2012
Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinomaLili Guo, Min Tang, Lifang Yang, et al.
The Journal of Nursing Administration|November 1, 1982
Collaboration benefits nursing service and educationH E Lazinski, S M Bode, K A Johnston, et al.
Nitric Oxide : Biology and Chemistry|September 8, 2004
Hypercholesterolemia impairs basal nitric oxide synthase turnover rate: a study investigating the conversion of L-[guanidino-(15)N(2)]-arginine to (15)N-labeled nitrate by gas chromatography--mass spectrometryRainer H Böger, Dimitrios Tsikas, Stefanie M Bode-Böger, et al.
Journal of the American Society of Nephrology : JASN|February 25, 2005
Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolaseFortunato Scalera, Jan T Kielstein, Jens Martens-Lobenhoffer, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease studyDanilo Fliser, Florian Kronenberg, Jan T Kielstein, et al.
European Journal of Pharmacology|January 15, 2020
Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseasesCan Cheng, Zhenzhen Li, Xu Zhao, et al.
Bioorganic & Medicinal Chemistry|May 18, 2025
Oxidative complexity: The role of ROS in the tumor environment and therapeutic implicationsTingfeng Shen, Yutong Wang, Linmao Cheng, et al.
Anticancer Research|April 13, 2001
Transactivation of AP-1 in AP-1-luciferase reporter transgenic mice by arsenite and arsenateC Huang, A M Bode, N Y Chen, et al.
Pageof 76

Showing results (321-330 of 756) with videos related to

Sort By:
Pageof 76
Cancer Research|May 17, 2008
The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer developmentDuo Zheng, Ann M Bode, Qing Zhao, et al.
Molecular Carcinogenesis|July 29, 2003
Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cellsAkira Kaji, Yiguo Zhang, Masaaki Nomura, et al.
International Journal of Molecular Medicine|January 24, 2012
Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinomaLili Guo, Min Tang, Lifang Yang, et al.
The Journal of Nursing Administration|November 1, 1982
Collaboration benefits nursing service and educationH E Lazinski, S M Bode, K A Johnston, et al.
Nitric Oxide : Biology and Chemistry|September 8, 2004
Hypercholesterolemia impairs basal nitric oxide synthase turnover rate: a study investigating the conversion of L-[guanidino-(15)N(2)]-arginine to (15)N-labeled nitrate by gas chromatography--mass spectrometryRainer H Böger, Dimitrios Tsikas, Stefanie M Bode-Böger, et al.
Journal of the American Society of Nephrology : JASN|February 25, 2005
Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolaseFortunato Scalera, Jan T Kielstein, Jens Martens-Lobenhoffer, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease studyDanilo Fliser, Florian Kronenberg, Jan T Kielstein, et al.
European Journal of Pharmacology|January 15, 2020
Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseasesCan Cheng, Zhenzhen Li, Xu Zhao, et al.
Bioorganic & Medicinal Chemistry|May 18, 2025
Oxidative complexity: The role of ROS in the tumor environment and therapeutic implicationsTingfeng Shen, Yutong Wang, Linmao Cheng, et al.
Anticancer Research|April 13, 2001
Transactivation of AP-1 in AP-1-luciferase reporter transgenic mice by arsenite and arsenateC Huang, A M Bode, N Y Chen, et al.
Pageof 76